MedTrace Logo

Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus

NCT02794363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-06-09

No results posted yet for this study

Summary

15 patients with biopsy proven active vulvar lichen sclerosus will be recruited by a clinic specializing in vulvar disorders. This study consists of a 2 week screening period and a 12-week treatment period. Participants will receive two separate treatments of autologous platelet rich plasma separated by 6 weeks. A repeat biopsy will be performed 6 weeks after the second autologous platelet rich plasma injection

Conditions

  • Lichen Sclerosus

Interventions

BIOLOGICAL

Autologous platelet rich plasma

5cc of autologous platelet rich plasma derived from 50cc of whole blood will be injected into vulvar skin.

Sponsors & Collaborators

  • Center for Vulvovaginal Disorders

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-01-31
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794363 on ClinicalTrials.gov